Introduction
NK cell cytotoxicity is regulated by triggering as well as inhibitory signals (1) . A two-step model suggests that initial activation of NK cell cytotoxicity is modulated by downregulating signals, resulting from binding of inhibitory receptors on NK cells to MHC class I molecules on target cells (2) . Thus, triggering proceeds as a default pathway unless the dominant negative signal is elicited (3, 4) , which implies the negative signals as critical to avoid autoreactivity. The positive signals that trigger NK cell cytotoxicity in defined biological situations are poorly characterized, despite the fact that several activating receptors have been identified (reviewed in 5). In contrast, the inhibitory pathways, in the mouse mediated by lectin-like Ly49 and CD94/NKG2 receptors, are better known. The Ly49 receptors, which interact with various alleles of classical MHC class I molecules, are expressed by subsets of NK cells in a complex, as yet not fully understood, Correspondence to: P. Höglund Transmitting editor: J. F. Bach
Received 10 June 1998, accepted 20 April 1999 pattern (2) . In addition to Ly49 receptors, many NK cells also express CD94/NKG2, an inhibitory receptor that interacts with the non-classical MHC class I molecule Qa-1 complexed with peptides derived from classical MHC class I molecules (6, 7) . The genes for these inhibitory receptors are all located in the NK complex on mouse chromosome six (8) . At least nine Ly49 and two NKG2 genes are known. In contrast, CD94 appears to be encoded by a single gene. It has been proposed that self tolerance in mature NK cells depend on expression of Ly49 receptors. If every NK cell expresses at least one receptor for self MHC class I, they will be unable to kill normal self cells (9) . The finding that NK cells can kill normal self cells if the relevant Ly49 receptors on the NK cells are blocked with antibodies is in line with this hypothesis (10) (11) (12) . Similarly, MHC class I disparate non-self cells (i.e. allogeneic or MHC class I -lymphoblasts) are killed by NK cells because they lack some self MHC class I molecules (3, 4) and Ly49 receptors on all NK cells are therefore not engaged. Thus, NK cells express triggering receptors for normal self cells that are allowed to dominate when the interaction between inhibitory receptors and MHC class I is disrupted.
An important question is how the balance between positive and negative signals is tuned during NK cell development to avoid autoreactivity in the maturing NK cell population. For example, how is expression of inhibitory receptors regulated in time and how does this relate to the capacity of NK cells to kill different target cells? It was recently shown that Ly49 expression is absent from birth and that the numbers of Ly49 ϩ NK cells in the spleen reach adult levels only after several weeks (13, 14) . Interestingly, the kinetics of Ly49 receptor acquisition parallels the development of certain NK cell manifestations, such as the ability to kill YAC-1 cells in vitro (15) and to mediate rejection of MHC incompatible bone marrow in vivo (16) . This association suggests that in order for an NK cell to acquire full effector functions, expression of Ly49 receptors is required. However, direct evidence for an association between NK cell function and Ly49 receptor expression has not been demonstrated.
To study this, an in vitro system that would mimic normal in vivo differentiation of NK cells, including the expression of Ly49 receptors, would be useful. We evaluated the previously described long-term bone marrow culture (LTBMC) system in this respect (17) (18) (19) . In the LTBMC, bone marrow cells are first cultured without addition of growth factors for 4 weeks. During this period cellularity drops to 1-2% of the input number and only adherent stromal cells surrounded by few non-adherent round cells are observed. At this stage, stimulation with IL-2 for 2 weeks leads to a large expansion of cells in the culture, which in the end results in a virtually pure population of NK1.1 ϩ cells (18) . Previous experiments have shown that such LTBMC-derived NK cells share many properties of mature NK cells, including high YAC-1 killing ability (17) (18) (19) . In this report, we compared LTBMC-derived NK cells with NK cells derived from a short-term spleen culture (STSC) with regard to cytotoxic capacity and the expression of inhibitory Ly49 receptors. We conclude that the NK cells generated in these two ways are severely different. While most STSC-derived NK cells expressed Ly49 receptors, LTBMCderived NK cells lacked to a large extent, but not completely, Ly49 receptor expression. Furthermore, LTBMC-derived NK cells differed from STSC-derived NK cells in that they failed to kill MHC class I -lymphoblasts, and could not distinguish between MHC class I -and MHC class I ϩ tumor target cells. Interestingly, the triggering defect against MHC class Ilymphoblasts was confined to the Ly49 -NK cell population: the few Ly49 ϩ NK cells present in the LTBMC displayed a normal pattern of cytotoxicity. These results show for the first time that acquisition of Ly49 receptors is associated with the capacity to kill certain normal target cells. We hypothesize that this link is important to avoid NK cell killing of self cells during some stages of NK cell development.
Methods
Tumor cell lines Tumor cell lines were cultured in RPMI 1640 supplemented with 5% FCS (v/v). YAC-1 is a Moloney murine leukemia virusinduced T cell lymphoma of the A/Sn strain. RMA is a subline of the Raucher virus-induced T cell lymphoma RBL-5 (H-2 b ) and RMA-S is a TAP2 -variant of RMA. B16 is a B6-derived melanoma cell line (H-2 b ) and P815 is a mastocytoma cell line derived from the DBA/2 strain (H-2 d ).
Generation of NK cells in LTBMC and STSC
To generate LTBMC cells, bone marrow was collected from femurs of B6 mice (by flushing the bone marrow cavity with PBS) and cultured at 2.5ϫ10 6 cells/ml for 4 weeks in RPMI 1640 medium supplemented with 5% FCS, L-glutamine, penicillin, streptomycin and 2-mercaptoethanol. After 4 weeks, 1000 U/ml rIL-2 was added and 13-15 days later experiments were performed. To generate STSC cells, erythrocytedepleted spleen cells were cultured for 4 days at 2.5ϫ10 6 cells/ml in α-MEM supplemented with 5% FCS, 10 mM HEPES, 2-mercaptoethanol, penicillin, streptomycin and 1000 U/ml rIL-2. Both LTBMC and STSC cultures were grown under 10% CO 2 conditions. Generation of concanavalin A (Con A)-activated T cell blasts and in vitro cytotoxicity assay Spleen cells were depleted from erythrocytes and incubated for 48 h (37°C) at 2ϫ10 6 cells/ml in RPMI 1640 medium supplemented with 5% FCS, penicillin, streptomycin and 3 µg/ml Con A (Sigma, St Louis, MO). After labeling of target cells with 51 Cr (for 1 h at 37°C), cells were diluted to the proper concentration in medium. Each E:T ratio was assayed in triplicate and 2ϫ10 3 -5ϫ10 3 target cells were used per well depending on the experiment. After 4 h of incubation, 100 µl of supernatant was harvested and the radioactivity of each sample was determined by counting γ radiation.
Flow cytometry and cell sorting
The following mAb were used: NK1.1 [PK136; phycoerythrin (PE)-conjugated], CD3 (145-2C11; FITC-conjugated), B220 (RA3-6B2; PE-conjugated), CD69 (H1.2F3; FITC-conjugated), Ly49A (A1; biotinylated), Ly49C/I (5E6; biotinylated) and Ly49G2 (4D11; FITC-conjugated). The anti-Ly49G2-producing hybridoma (4D11) was originally acquired from ATCC (Rockville, MD). All other antibodies were purchased from PharMingen (San Diego, CA). To stain cells for flow cytometry, cells from LTBMC and STSC were washed once with PBS, incubated with directly labeled specific antibody for 30-60 min on ice and washed again prior to analysis. To sort Ly49 ϩ and Ly49 -NK cells, LTBMC-derived cells were stained with antibodies against the inhibitory Ly49 molecules A, C/I and G2 (directly FITC-conjugated antibodies or biotinylated antibodies followed by streptavidin-FITC) together with NK1.1-PE. Sorted cells were replated in fresh medium with IL-2 and were allowed to recover in the incubator overnight before testing for killing ability against lymphoblasts the next day. Analytical flow cytometry was performed using a FACScan (Becton Dickinson, Mountain View, CA). Dead cells were excluded by means of an electronic gate in the forward and side scatter profile. After acquisition, the FACS profiles were analyzed using CellQuest software. Cell sorting experiments were performed using a FACS Vantage (Becton Dickinson). (Fig. 1) . LTBMC-derived NK cells were therefore classified as activated NK cells. With the exception of CD69 staining, that was not previously analyzed, this result was noted also in previous studies (17) (18) (19) . A large difference was found in the expression of Ly49 receptors. In the experiment shown in this study, 25% of NK1.1 ϩ cells were Ly49A ϩ , 31% were Ly49C/ I ϩ and 59% were Ly49G2 ϩ in the STSC, while among LTMBCderived NK cells, 4% were Ly49A ϩ , 1% were Ly49C/I ϩ and 5% were Ly49G2 ϩ (Fig. 2) . was already reported (17) (18) (19) , LTBMC-derived NK cells were always efficient in killing the prototype NK cell target YAC-1. However, against other targets, the cytotoxic potency of LTBMC-derived NK cells was more unpredictable than that of STSC-derived NK cells. In some experiments, LTBMCderived NK cells were as efficient as those from STSC in tumor cell killing, both against hematopoietic tumors and tumors originating from other tissues (Fig. 3) . However, in other experiments, morphologically normal LTBMC cultures displayed very poor killing ability. Table 2 lists nine consecutive experiments in which LTBMC-and STSC-derived NK cells were compared with respect to killing capacity against three tumor cell lines: YAC-1, RMA and RMA-S, and against two normal target cells, β 2 m ϩ and β 2 m -Con A blasts. With regard to the tumor targets, STSC-derived NK cells rarely failed to kill any of them (Table 2 ). In contrast, despite being always cytotoxic against YAC-1 cells, LTBMC-derived NK cells sometimes completely failed to kill the RMA and RMA-S tumors (Table 2 , experiments 2, 4 and 7), but sometimes killed them well (Table 2, experiments 1, 3 and 8) . Interestingly, in the cases where RMA and RMA-S target cells were killed, we were surprised to find no difference in sensitivity between the two target cells, which was in striking contrast to STSCderived NK cells, that almost always killed the MHC class I -RMA-S cells better than MHC class I ϩ RMA (Table 2) .
LTBMC-derived NK cells were also tested against β 2 m -lymphoblasts. Here, a different pattern appeared. In contrast to the clear capacity (although variable) to kill both RMA and RMA-S targets, LTBMC-derived NK cells were more consistently unable to kill both βϾ 2 m -and β 2 m ϩ lymphoblasts (Table 2) . This was again different from STSC-derived NK cells, that always killed β 2 m -lymphoblasts better than β 2 m ϩ (Table 2) . However, LTBMC-derived NK cells did occasionally manage to kill the former targets (i.e. Table 2 , experiment 8), but the lack of killing against β 2 m -targets was the most commonly observed result (Table 1 , experiments 2, 5, 6, 7 and 9). It should be noted that although the level of YAC-1 lysis was in the lower range (Ͻ40%) in many of the experiments We wondered whether the differences in target cell specificity of LTBMC-derived NK cells relative to STSC-derived was related to the Ly49 deficiency in the LTBMC. In particular, we were intrigued by the inability of LTBMC-derived NK cells to kill β 2 m -lymphoblasts, something that STSC-derived NK cells never failed to do. To investigate this directly, we separated Ly49 ϩ and Ly49 -LTBMC-derived NK cells by cell sorting (Fig. 4) , and tested the two populations separately for ability to lyse β 2 m -lymphoblasts. Strikingly, when Ly49 ϩ NK cells were enriched and tested separately, they displayed completely normal killing of β 2 m -lymphoblasts (Table 3) . In contrast, Ly49 -NK cells were always unable to kill β 2 mlymphoblasts, despite good killing against YAC-1 cells (Table  3 ). This result showed that Ly49 receptor expression was associated with the ability to kill normal self cells and also suggested that the occasional discriminatory capacity of unsorted LTBMC-derived NK cells we observed (especially pronounced in experiment 3, Table 3 , but also seen in experiment 2, Table 3 and experiment 8, Table 2 ) could be due to an unusually high percentage, or activity, of Ly49 ϩ NK cells in those cultures.
Discussion
We report that, in our hands, the LTBMC system failed to give rise to mature NK cells with similar characteristics as NK cells generated from the spleen. We noted some similarities, but also some interesting differences between these two NK cell populations, both with regard to function and to expression of cell surface markers.
Phenotypic profiles LTBMC-and STSC-derived NK cells were both positive for cell surface antigens characteristic for activated NK cells, such as the NKR-P1 allele NK1.1 and the early activation antigen CD69. In agreement with earlier reports investigating LTBMC-derived NK cells, we found that most of the LTBMCderived NK cells were negative for B220, a high molecular isoform of the CD45 antigen. B220 has been suggested as a marker for cytokine-activated NK cells with lytic ability (20) and an interesting possibility is therefore that the lack of B220 is somehow related to the cytotoxic deficiency of LTBMCderived NK cells. However, the role of B220 in NK cell Values are expressed as percent specific lysis with E:T ratios of 50:1 and 17:1. cytotoxicity is uncertain, given that NK cells in CD45 -mice, lacking B220, have normal cytotoxicity (21) . The functional significance of the lack of B220 expression in the LTBMC therefore requires further study.
Another phenotypic difference was the profound deficiency in expression of inhibitory Ly49 receptors seen in LTBMCderived NK cells. Previous results from other in vitro systems also demonstrated deficient Ly49 receptor expression on NK cells generated from immature precursors (22) (23) (24) (25) . One explanation as to why full differentiation of NK cells is not seen in these systems could be that that the final differentiation of effector NK cells leading to Ly49 expression requires a special combination of growth factors that is difficult to replicate satisfactorily in vitro. Relevant to this notion, we have tried to induce Ly49 expression in all NK cells in the LTBMC by adding different cytokines during the IL-2 induction phase (including IL-15), but without success (data not shown). It is also possible that the in vitro culture systems used fail to reproduce the correct microenvironment present in vivo that, in combination with the right growth factors, would be needed to ensure proper contacts between potentially selecting stromal cells and the NK cell precursor during differentiation. However, not all NK cells in the LTBMC were Ly49 -. We consistently found 3-5% of the NK cells staining positive for either one of the three antibodies against inhibitory Ly49 molecules we tested, directed against Ly49A, Ly49C/I and Ly49G2. In the spleen, those three antibodies in combination stained~80-90% of all NK cells, but in the LTBMC, the total number of cells expressing any of those Ly49 molecules varied between 10 and 15%. Given the normal cytotoxic capacity of those NK cells (see below), they probably represent fully mature NK cells, similar to those found in the spleen. However, it is unlikely that those NK cells originate from contaminating mature cells from the original bone marrow isolate, because before addition of IL-2, the bone marrow is left untouched in the culture flask for 4 weeks, a step which should eliminate any fully differentiated mature NK cells present in the culture (19) . In addition, no cells expressing NK1.1 could be detected in the culture after 4 weeks of starvation, suggesting that no mature NK cells were present at the start of the IL-2 culture (data not shown and 19).
Why are few, but not all, NK cells Ly49 ϩ in the LTBMC? One possibility is that the initial step in NK cell development could be initiated in the NK cell precursor with a certain probability by an intrinsic developmental pathway, independent of exogenous growth factors. Alternatively, the correct maturation factors may be present in the LTBMC only at a suboptimal level, which, due to competition for limited resources, is sufficient to trigger maturation of few, but not all, NK cells. A third possibility is that the Ly49 -LTBMCderived NK cells represent an expanded sub-population of normal fully differentiated NK cells that do not express inhibitory receptors and whose survival is particularly favored by the LTBMC culture conditions. At present, we cannot distinguish between these alternatives.
Cytotoxic function
Two intriguing observations were made with regard to the cytotoxic function of LTBMC-derived NK cells. The first was that they were unable to distinguish between RMA and RMA-S tumor cells, despite the fact that RMA-S cells are severely deficient in MHC class I expression and that RMA express high levels (26) . This result was surprising in light of recent data showing that IL-2-activated splenic NK cells from neonatal mice (Ͻ10 days) were clearly able, despite Ly49 deficiency, to distinguish between self cells with high MHC class I expression from those with low expression, including the RMA/RMA-S target cell pair (13, 14) . One possible difference between neonatal and LTBMC-derived NK cells could be that the former, but not the latter, express inhibitory receptors different from Ly49, candidates of which are CD94/ NKG2 receptors (6, 7, 27, 28) . This hypothesis would explain why neonatal, but not LTBMC-derived, NK cells can distinguish RMA from RMA-S cells. How would such a difference come about? In this respect, it may be important that the LTBMC protocol starts with a 4 week resting period of the input bone marrow, during which there is excessive cell death and by this selective enrichment of multipotent hematopoietic bone marrow-derived stem cells (17) (18) (19) . In the other culture systems, the starting material is obtained either from outside of the bone marrow or by direct sorting of previously identified committed progenitors from bone marrow, which in both cases may lead to expansion of stem cells from later stages in NK cell development (22) (23) (24) (25) . Future studies will be needed to carefully compare expression of inhibitory receptors and cytotoxic function on NK cells derived from the various culture systems that exist.
The second observation was that Ly49 -LTBMC-derived NK cells were incapable of killing non-transformed β 2 m -cells despite the fact that they were cytotoxic against YAC-1 cells. Since β 2 m -lymphoblasts are normally very good targets for activated NK cells (3, 4) , this result demonstrated that Ly49 -and Ly49 ϩ LTBMC-derived NK cells were qualitatively different in some aspects of target cell specificity, and that there exists a link between the ability to be triggered by normal self cells and expression of inhibitory Ly49 receptors. This is an interesting result in relation to self tolerance development. It has been suggested that NK cell tolerance depends upon NK cell expression of allele-specific Ly49 receptors (9, 29) . This theory is based on the notion that NK cells normally possess activating pathways triggered by self cells. If these activating pathways would be triggered in the absence of inhibitory receptors, a risk for autoimmune cytotoxicity would prevail. It therefore makes sense that lack of inhibitory receptors would preclude expression of triggering pathways activated by normal self cells. Also in this case, the comparison with Ly49 -neonatal NK cells, which were capable of not only distinguishing RMA from RMA-S cells but also to kill MHC class I -lymphoblasts, is interesting. Perhaps the inhibitory receptors different from Ly49 that are expressed by neonatal NK cells are sufficient to signal that self tolerance is secured. This in turn would allow the NK cell to go through the differentiation program regulating expression of a full set of activating receptors. For reasons unknown at this point, this checkpoint would not be passed in the LTBMC and LTBMC-derived NK cells would therefore be prevented to express triggering receptors for self cells.
Finally, Ly49 -NK cells were clearly capable of killing tumor cells despite the absence of lymphoblast killing. How can this be explained? There are several lines of evidence to suggest that tumor cells and lymphoblasts are recognized differently (30) . For example, NK cells in mice lacking the CD4 homologue LAG3 showed impaired tumor recognition in vitro, but were perfectly capable of mediating rejection of β 2 m -bone marrow grafts in vivo (31) . Another example is self tolerance in β 2 m -mice. β 2 m -NK cells have completely lost the capacity to reject β 2 m -bone marrow grafts and to kill β 2 m -Con A lymphoblast targets, while the ability to be triggered by tumor-specific activating ligands is largely unaffected (32) . Thus, NK cells may use, at least in part, different recognition systems in the killing of lymphoblasts versus tumor target cells. Our data suggest that the function of those triggering structures, be it specific receptors or different intracellular signaling pathways, are regulated independently, such that one can be allowed to develop normally separated from each other.
In summary, we have reported a correlation between expression of Ly49 receptors and cytotoxic function; in LTBMC-derived NK cells, expression of Ly49 receptors was necessary to allow killing of lymphoblasts deficient in MHC class I expression. We suggest that this correlation reflects a developmentally ordered expression of triggering versus inhibitory MHC class I-specific receptors during development. In this model, the inhibitory receptors must be expressed first to avoid autoreactivity during NK cell maturation.
